08 April 2026 : Clinical Research
Efficacy and Safety of Liposomal Bupivacaine in Direct Anterior Approach Total Hip Arthroplasty: A Retrospective Cohort Study
Ye Chen
ABCDEF 1, Chunxiao Zhang AD 2, Lanyong Chen B 1, Yong He B 1, Linling Zhang B 1, Songfeng Hu AG 1,2*
DOI: 10.12659/MSM.951717
Med Sci Monit 2026; 32:e951717
Table 4 Comparison of white blood cell (WBC) counts and C-reactive protein (CRP) levels between the liposomal bupivacaine (LB) and ropivacaine groups.
| Item | LB group (n=61) | Ropivacaine group (n=68) | P value |
|---|---|---|---|
| WBC (×10 L) | |||
| Preoperative | 6.08±2.21 | 6.51±2.35 | 0.394 |
| Postoperative day 1 | 9.21±2.76 | 9.40±3.18 | 0.961 |
| Postoperative day 7 | 6.37±2.09 | 6.20±1.91 | 0.834 |
| CRP (mg/L) | |||
| Preoperative | 11.80±20.05 | 13.03±17.43 | 0.216 |
| Postoperative day 1 | 50.22±36.55 | 51.90±33.46 | 0.570 |
| Postoperative day 7 | 21.98±19.64 | 20.88±15.90 | 0.747 |
| Data are presented as mean±SD. | |||